News
Opioid prescribing laws having an impact
August 11, 2021
The number of days an opioid was prescribed for each Medicare beneficiary decreased by 11.6 days in 2018 in states that imposed duration limits.
News
COVID-19 mitigation measures led to shifts in typical annual respiratory virus patterns
August 11, 2021
“Clinicians should be aware of increases in some respiratory virus activity and remain vigilant for off-season increases.”
News
Myocarditis in adolescents after COVID-19 vaccine typically mild
August 11, 2021
“Despite the risks of myocarditis associated with vaccination, the benefits of vaccination likely outweigh risks in children and adolescents.”
![1]()
News
Major musculoskeletal surgery in children with medically complex conditions
August 10, 2021
The guide meticulously details the steps required to successfully prepare for an operation and post-operative recovery.
![1]()
News
Surge of new child COVID cases continues for 6th consecutive week
August 10, 2021
Upward trend in vaccine initiation is now in its 4th week among 12- to 15-year-olds.
News
Docs fight back after losing hospital privileges, patients, and income
August 10, 2021
Physicians in St. Louis lost their hospital privileges when the hospital entered into an exclusive contract with other physicians. They’re losing patients and money.
News
Patients with diabetes more likely to be hospitalized, especially with foot infection
August 9, 2021
Participants with diabetes faced a 67% increased risk of infection-related hospitalization, compared with those without diabetes.
![1]()
Opinion
Microlearning during the pandemic
August 9, 2021
Microlearning occurs when clinicians turn to their smartphones or tablets in order to discover something, answer a question, or complete a task.
![1]()
News
Fauci says ‘unprecedented’ conditions could influence COVID vaccine approval for kids
August 6, 2021
“If I were a [non-COVID] virus looking for a niche, I would be really confused,” Dr. Fauci told pediatric hospitalists.
![1]()
News
Injectable monoclonal antibodies prevent COVID-19 in trial
August 6, 2021
The cocktail of casirivimab and imdevimab reduced the relative risk of infection by 72% in patients at high risk of infection.
